Zosano Pharma Corporation (ZSAN) Company Profile
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability. The Company’s short-wear-time transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an approved drug and attached to an adhesive patch. When the patch is applied with its hand-held applicator, the microneedles painlessly penetrate the skin, resulting in rapid dissolution and absorption of the drug coating through the capillary bed. Its product candidates include ZP-Triptan, ZP-Glucagon and ZP-PTH. ZP-PTH is a formulation of teriparatide, a synthetic form of parathyroid hormone. ZP-Glucagon is a formulation of glucagon.
News about ZSAN
Iconix, PPL Corp. Slip into Tuesday’s 52-Week Low Club
December 26, 2017: Here are four stocks trading with heavy volume among 35 equities making new 52-week lows in Tuesday’s session. On the NYSE advancers led decliners by about 4 to 3 and on the Nasdaq, advancers and decliners finished about even...Read More>>>
The 10 Best Penny Stocks to Watch in March 2017
Here's a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLP...Read More>>>